Clinical Trials on Mitochondrial Alteration in Switzerland
Total 9 results
-
Mclean HospitalYale University; University of LausanneNot yet recruitingCognitive Impairment | Schizophrenia and Related Disorders | Mitochondrial AlterationUnited States, Switzerland
-
University Hospital Inselspital, BerneCompletedMitochondrial Diseases | Mitochondrial Myopathies | Mitochondrial CytopathiesSwitzerland
-
University of BernITI FoundationCompleted
-
University Hospital, GenevaCompletedRenal AlterationSwitzerland
-
University Children's Hospital, ZurichCompletedWounds and Injuries | Child | Laceration | Sutures | Tissue AdhesivesSwitzerland
-
Zurich University of Applied SciencesSwiss National Science Foundation; Nursing Science Foundation SwitzerlandUnknownDiabetic Foot UlcerSwitzerland
-
University of applied sciencesSwiss National Science FoundationNot yet recruitingNeck Pain | Pain, Acute | Pain, Chronic | Pain Catastrophizing | Whiplash | Psychosocial Functioning | Alteration of Cognitive Function | Activity, Motor | Overactivity; BehaviorSwitzerland
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland